Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
456K
-
Shares change
-
-4.08K
-
Total reported value, excl. options
-
$9.48M
-
Value change
-
-$83.6K
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$20.84
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2014
9 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2014.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 456K shares
.
Largest 9 shareholders include Parametric Portfolio Associates LLC (231K shares), RMB Capital Management, LLC (86.5K shares), World Asset Management Inc (81K shares), GLENMEDE TRUST CO NA (24.9K shares), Ameriprise Financial Inc (16.4K shares), Calvert Investment Management Inc. (14.8K shares), Hexavest Inc. (1.13K shares), PNC Financial Services Group, Inc. (318 shares), and PRIVATE TRUST CO NA (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.